![Daniel J. Burge](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Daniel J.
Burge worked as a Vice President of Clinical Research & Development at Amgen, Inc. and Immunex Corp.
from 2000 to 2003.
He then worked as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle from 2004 to 2008.
After that, he held the position of Senior Vice President of Clinical Development at Dermira, Inc. and Chief Medical Officer & Head of Clinical Development at Forte Biosciences, Inc. Dr. Burge holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from Taylor University.
Eerdere bekende functies van Daniel J. Burge
Bedrijven | Functie | Einde |
---|---|---|
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Hoofd Techniek/Wetenschap/O&O | 29-08-2008 |
AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2003 |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 |
DERMIRA, INC. | Hoofd Techniek/Wetenschap/O&O | - |
FORTE BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Daniel J. Burge
Thomas Jefferson University | Doctorate Degree |
Taylor University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
AMGEN INC. | Health Technology |
FORTE BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Dermira, Inc.
![]() Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |